Cargando…

317. Risk Factors for Fungal Prosthetic Joint Infections (PJIs)

BACKGROUND: Fungal PJIs are rare and often associated with poor outcome. Risk factors are not well described and thus, we sought to determine such risks among patients cared for at two large academic hospitals. METHODS: This was a retrospective case–control study among patients with PJI from 2006 to...

Descripción completa

Detalles Bibliográficos
Autores principales: Riaz, Talha, Tande, Aaron, Steed, Lisa L, Demos, Harry, Salgado, Cassandra, Osmon, Douglas, Marculescu, Camelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254834/
http://dx.doi.org/10.1093/ofid/ofy210.328
_version_ 1783373816778457088
author Riaz, Talha
Tande, Aaron
Steed, Lisa L
Demos, Harry
Salgado, Cassandra
Osmon, Douglas
Marculescu, Camelia
author_facet Riaz, Talha
Tande, Aaron
Steed, Lisa L
Demos, Harry
Salgado, Cassandra
Osmon, Douglas
Marculescu, Camelia
author_sort Riaz, Talha
collection PubMed
description BACKGROUND: Fungal PJIs are rare and often associated with poor outcome. Risk factors are not well described and thus, we sought to determine such risks among patients cared for at two large academic hospitals. METHODS: This was a retrospective case–control study among patients with PJI from 2006 to 2016. Each fungal PJI case was matched 1:1 with a bacterial PJI control for joint location (hip, knee, and shoulder) and year of diagnosis. We compared demographics (age, sex, and race), co-morbid conditions (BMI, diabetes, immunosuppression, renal disease, and antibiotic use), and clinical characteristics (joint age, wound factors, laboratory data, previous joint surgeries, and previous PJI) between fungal and bacterial PJI groups using chi square/Fisher’s exact or Wilcoxon rank-sum test. Risk factors statistically (P < 0.05) or clinically significant were included in a multivariable logistic regression (MVR) model in stepwise fashion (SAS 9.4, Cary, North Carolina). RESULTS: Forty-one fungal PJI occurred over the study period and 61% were due to Candida albicans. Median age was 64.7 years, 51% were females, and 87% were White. The hip was involved in 51.2%, followed by the knee (46.3%), and shoulder (2.4%). There were no significant differences in joint age or co-morbid conditions. Compared with bacterial PJI, those with fungal PJI were more likely to have received antibiotics within the past 3 months (70.7% vs. 34%, P = 0.001), had wound drainage lasting more than 5 days (48% vs. 9%, P = 0.0002), had a lower median CRP (2.95 mg/dL vs. 5.99, P = 0.013) and synovial fluid wbc count (13,953 cells/mm(3) vs. 33,198, P = 0.007), and a higher proportion of prior two-stage exchanges (82.9% vs. 53.6%, P = 0.008). After MVR, controlling for the center, presence of wound drainage for more than 5 days (OR, 7.3; 95% confidence interval [CI], 2.02–26.95) and receipt of antibiotics within the past 3 months (OR, 3.4; 95% CI, 1.2–9.3) were factors significantly associated with fungal PJI. CONCLUSION: In our study, Candida albicans was the most common species in fungal PJIs. The presence of wound drainage for more than 5 days and receipt of antibiotics within the past 3 months were independent risk factors for fungal PJI among a cohort of PJI patients. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6254834
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-62548342018-11-28 317. Risk Factors for Fungal Prosthetic Joint Infections (PJIs) Riaz, Talha Tande, Aaron Steed, Lisa L Demos, Harry Salgado, Cassandra Osmon, Douglas Marculescu, Camelia Open Forum Infect Dis Abstracts BACKGROUND: Fungal PJIs are rare and often associated with poor outcome. Risk factors are not well described and thus, we sought to determine such risks among patients cared for at two large academic hospitals. METHODS: This was a retrospective case–control study among patients with PJI from 2006 to 2016. Each fungal PJI case was matched 1:1 with a bacterial PJI control for joint location (hip, knee, and shoulder) and year of diagnosis. We compared demographics (age, sex, and race), co-morbid conditions (BMI, diabetes, immunosuppression, renal disease, and antibiotic use), and clinical characteristics (joint age, wound factors, laboratory data, previous joint surgeries, and previous PJI) between fungal and bacterial PJI groups using chi square/Fisher’s exact or Wilcoxon rank-sum test. Risk factors statistically (P < 0.05) or clinically significant were included in a multivariable logistic regression (MVR) model in stepwise fashion (SAS 9.4, Cary, North Carolina). RESULTS: Forty-one fungal PJI occurred over the study period and 61% were due to Candida albicans. Median age was 64.7 years, 51% were females, and 87% were White. The hip was involved in 51.2%, followed by the knee (46.3%), and shoulder (2.4%). There were no significant differences in joint age or co-morbid conditions. Compared with bacterial PJI, those with fungal PJI were more likely to have received antibiotics within the past 3 months (70.7% vs. 34%, P = 0.001), had wound drainage lasting more than 5 days (48% vs. 9%, P = 0.0002), had a lower median CRP (2.95 mg/dL vs. 5.99, P = 0.013) and synovial fluid wbc count (13,953 cells/mm(3) vs. 33,198, P = 0.007), and a higher proportion of prior two-stage exchanges (82.9% vs. 53.6%, P = 0.008). After MVR, controlling for the center, presence of wound drainage for more than 5 days (OR, 7.3; 95% confidence interval [CI], 2.02–26.95) and receipt of antibiotics within the past 3 months (OR, 3.4; 95% CI, 1.2–9.3) were factors significantly associated with fungal PJI. CONCLUSION: In our study, Candida albicans was the most common species in fungal PJIs. The presence of wound drainage for more than 5 days and receipt of antibiotics within the past 3 months were independent risk factors for fungal PJI among a cohort of PJI patients. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2018-11-26 /pmc/articles/PMC6254834/ http://dx.doi.org/10.1093/ofid/ofy210.328 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Riaz, Talha
Tande, Aaron
Steed, Lisa L
Demos, Harry
Salgado, Cassandra
Osmon, Douglas
Marculescu, Camelia
317. Risk Factors for Fungal Prosthetic Joint Infections (PJIs)
title 317. Risk Factors for Fungal Prosthetic Joint Infections (PJIs)
title_full 317. Risk Factors for Fungal Prosthetic Joint Infections (PJIs)
title_fullStr 317. Risk Factors for Fungal Prosthetic Joint Infections (PJIs)
title_full_unstemmed 317. Risk Factors for Fungal Prosthetic Joint Infections (PJIs)
title_short 317. Risk Factors for Fungal Prosthetic Joint Infections (PJIs)
title_sort 317. risk factors for fungal prosthetic joint infections (pjis)
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254834/
http://dx.doi.org/10.1093/ofid/ofy210.328
work_keys_str_mv AT riaztalha 317riskfactorsforfungalprostheticjointinfectionspjis
AT tandeaaron 317riskfactorsforfungalprostheticjointinfectionspjis
AT steedlisal 317riskfactorsforfungalprostheticjointinfectionspjis
AT demosharry 317riskfactorsforfungalprostheticjointinfectionspjis
AT salgadocassandra 317riskfactorsforfungalprostheticjointinfectionspjis
AT osmondouglas 317riskfactorsforfungalprostheticjointinfectionspjis
AT marculescucamelia 317riskfactorsforfungalprostheticjointinfectionspjis